Prostatic small cell carcinoma (PSCC) is a distinct clinical phenotype of prostate cancer. Although rare, this phenotype is highly aggressive with very high mortality. Due to this, it is imperative ...

The findings were consistent with those of metastatic prostatic carcinoma with neuroendocrine differentiation, similar to the previous histological findings from the prostate. A multidisciplinary ...

Proper identification of ductal carcinoma of the prostate has led to the application of appropriate therapies, including surgical resection, radiation therapy, hormonal depletion therapy and ...

Pathologic identification is based upon a papillary morphology without basal cells, and confirmed by positive immunostaining of PSA and prostatic acid phosphatase. Since ductal carcinoma merits a ...

May increase growth of subclinical prostatic carcinoma. Monitor for venous thromboembolism; discontinue if suspected. Inform patients of possible increased risk of MI, stroke. Elderly. Young children.